Reliability of follicle-stimulating hormone measurements in serum

被引:15
作者
Alan A Arslan
Anne Zeleniuch-Jacquotte
Annekatrin Lukanova
Sabina Rinaldi
Rudolf Kaaks
Paolo Toniolo
机构
[1] New York Univ. School of Medicine, New York, NY
[2] Hormones and Cancer Group, International Agency Research Cancer, Lyon
关键词
Postmenopausal Woman; Luteinizing Hormone; Premenopausal Woman; Mixed Effect Regression Model; Result Intraclass Correlation;
D O I
10.1186/1477-7827-1-49
中图分类号
学科分类号
摘要
Background. Follicle-stimulating hormone (FSH), a member of gonadotropin family, is critical for follicular maturation and ovarian steroidogenesis. Serum FSH levels are known to fluctuate during different phases of menstrual cycle in premenopausal women, and increase considerably after the menopause as a result of ovarian function cessation. There is little existing evidence to guide researchers in estimating the reliability of serum FSH measurements. The objective of this study was to assess the reliability of FSH measurement using stored sera from an ongoing prospective cohort - the NYU Women's Health Study. Methods. Sixty healthy women (16 premenopausal, 44 postmenopausal), who donated at least two blood samples at approximately 1-year intervals were studied. An immunoradiometric assay using a sandwich monoclonal antibodies technique was used to measure FSH levels in serum. Results. The reliability of a single log-transformed FSH measurement, as determined by the intraclass correlation coefficient, was 0.70 for postmenopausal women (95% confidence interval (CI), 0.55-0.82) and 0.09 for premenopausal women (95% CI, 0-0.54). Conclusions. These results suggest that a single measurement is sufficient to characterize the serum FSH level in postmenopausal women and could be a useful tool in epidemiological research. For premenopausal women, however, the reliability coefficient was low, suggesting that a single determination is insufficient to reliably estimate a woman's true average serum FSH level and repeated measurements are desirable. © 2003 Arslan et al; licensee BioMed Central Ltd.
引用
收藏
页数:5
相关论文
共 23 条
[1]  
Rose M.P., Gaines Das R.E., Balen A.H., Definition and measurement of follicle stimulating hormone, Endocr. Rev., 21, pp. 5-22, (2000)
[2]  
Fevold H.L., Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion, Endocrinology, 28, pp. 33-36, (1941)
[3]  
Greep R.O., Van Dyke H.B., Chow B.F., Gonadotropin of swine pituitary: Various biological effects of purified thylkentrin (FSH) and pure matakentrin (ICSH), Endocrinology, 30, pp. 635-649, (1942)
[4]  
Kobayashi M., Nakano R., Ooshima A., Immunohistochemical localization of pituitary gonadotrophins and gonadal steroids confirms the 'two-cell, two-gonadotrophin' hypothesis of steroidogenesis in the human ovary, J. Endocrinol., 126, pp. 483-488, (1990)
[5]  
Hillier S.G., Whitelaw P.F., Smyth C.D., Follicular oestrogen synthesis: The 'two-cell, two-gonadotrophin' model revisited, Mol. Cell Endocrinol., 100, pp. 51-54, (1994)
[6]  
Erickson G.F., Magoffin D.A., Dyer C.A., Hofeditz C., The ovarian androgen producing cells: A review of structure/function relationships, Endocr. Rev., 6, pp. 371-399, (1985)
[7]  
Richards J.S., Hormonal control of gene expression in the ovary, Endocr. Rev., 15, pp. 725-751, (1994)
[8]  
Cramer D.W., Welch W.R., Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis, J. Natl. Cancer Inst., 71, pp. 717-721, (1983)
[9]  
Helzlsouer K.J., Alberg A.J., Gordon G.B., Longcope C., Bush T.L., Hoffman S.C., Comstock G.W., Serum gonadotropins and steroid hormones and the development of ovarian cancer, JAMA, 274, pp. 1926-1930, (1995)
[10]  
Akhmedkhanov A., Toniolo P., Zeleniuch-Jacquotte A., Pettersson K.S., Huhtaniemi I.T., Luteinizing hormone, its beta-subunit variant, and epithelial ovarian cancer: The gonadotropin hypothesis revisited, Am. J. Epidemiol., 154, pp. 43-49, (2001)